Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami J Barmada

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Nature Communications|May 19, 2022
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTDGopinath Krishnan, Denitza Raitcheva, Daniel Bartlett, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Molecular Visualization of Neuronal TDP43 Pathology <i>In Situ</i>Amanda L Erwin, Matthew L Chang, Martin G Fernandez, et al.
Brain : a Journal of Neurology|June 11, 2021
TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementiaHadjara Sidibé, Yousra Khalfallah, Shangxi Xiao, et al.
The Journal of Clinical Investigation|February 11, 2014
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defectsHaiyan Qiu, Sebum Lee, Yulei Shang, et al.
Acta Neuropathologica|March 31, 2023
C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTDPedro Ervilha Pereira, Nika Schuermans, Antoon Meylemans, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerabilityBilada Bilican, Andrea Serio, Sami J Barmada, et al.
Science Translational Medicine|June 7, 2013
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"Bilada Bilican, Andrea Serio, Sami J Barmada, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
TDP43 autoregulation gives rise to shortened isoforms that are tightly controlled by both transcriptional and post-translational mechanismsMegan M Dykstra, Kaitlin Weskamp, Nicolás B Gómez, et al.
Neurology and Therapy|October 17, 2023
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS SummitRita Sattler, Bryan J Traynor, Janice Robertson, et al.
Cell Reports|January 10, 2025
TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanismsMegan M Dykstra, Kaitlin Weskamp, Nicolás B Gómez, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Nature Communications|May 19, 2022
Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTDGopinath Krishnan, Denitza Raitcheva, Daniel Bartlett, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Molecular Visualization of Neuronal TDP43 Pathology <i>In Situ</i>Amanda L Erwin, Matthew L Chang, Martin G Fernandez, et al.
Brain : a Journal of Neurology|June 11, 2021
TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementiaHadjara Sidibé, Yousra Khalfallah, Shangxi Xiao, et al.
The Journal of Clinical Investigation|February 11, 2014
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defectsHaiyan Qiu, Sebum Lee, Yulei Shang, et al.
Acta Neuropathologica|March 31, 2023
C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTDPedro Ervilha Pereira, Nika Schuermans, Antoon Meylemans, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2012
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerabilityBilada Bilican, Andrea Serio, Sami J Barmada, et al.
Science Translational Medicine|June 7, 2013
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells"Bilada Bilican, Andrea Serio, Sami J Barmada, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
TDP43 autoregulation gives rise to shortened isoforms that are tightly controlled by both transcriptional and post-translational mechanismsMegan M Dykstra, Kaitlin Weskamp, Nicolás B Gómez, et al.
Neurology and Therapy|October 17, 2023
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS SummitRita Sattler, Bryan J Traynor, Janice Robertson, et al.
Cell Reports|January 10, 2025
TDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanismsMegan M Dykstra, Kaitlin Weskamp, Nicolás B Gómez, et al.
Pageof 9